CEACAM5 and colorectal cancer: Further modification includes the administration of the vaccinia-CEA-mucin 1 triad of costimulatory molecules, and the TRICOM (PANVAC-V) vaccine has been tested for metastatic liver cancer from colorectal cancer (NCT00103142) [95].